Fund Holdings — TFG Asset Management GP Ltd

Total Portfolio Value:
$757.50M
Total Bought:
$167.33M
Total Sold:
$25.89M
Net Transaction:
+$141.44M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
UiPath, Inc.CL A(PATH)30,950,00032,500,000+1,550,000$336.43M$417.30M55.09%+$80.87M
Kolibri Global Energy Inc6,834,5046,834,5040$33.85M$42.26M5.58%+$8.41M
Silence Therapeutics plcADS(SLN)764,2562,436,051+1,671,795$8.39M$26.63M3.51%+$18.23M
Pharvaris Nv
COM
295,627838,247+542,620$10.22M$26.59M3.51%+$16.37M
Ionis Pharmaceuticals, Inc.(IONS)97,173440,930+343,757$7.70M$19.69M2.60%+$11.98M
Autolus Therapeutics LtdADS9,500,0009,500,0000$15.20M$18.43M2.43%+$3.23M
Arrowhead Pharmaceuticals, Inc.(ARWR)130,484264,040+133,556$10.64M$17.28M2.28%+$6.65M
Lyft, Inc.CL A(LYFT)1,000,0001,000,0000$14.61M$15.01M1.98%+$400.0K
Workiva Inc.CL A(WK)250,000225,000-25,000$12.13M$14.98M1.98%+$2.85M
MBX Biosciences, Inc.(MBX)203,543220,647+17,104$11.24M$12.93M1.71%+$1.70M
Definium Therapeutics, Inc.(DFTX)286,990310,892+23,902$13.50M$11.83M1.56%-$1.67M
Sprinklr, Inc.CL A(CXM)2,200,0002,200,0000$11.35M$10.89M1.44%-$462.0K
Celldex Therapeutics, Inc.(CLDX)290,441295,941+5,500$10.81M$9.59M1.27%-$1.22M
Immunovant, Inc.(IMVT)255,934275,219+19,285$9.86M$9.30M1.23%-$564.2K
Harmony Biosciences Holdings, Inc.(HRMY)201,036226,677+25,641$7.32M$8.90M1.17%+$1.58M
Alkami Technology, Inc.(ALKT)600,284650,000+49,716$10.88M$8.90M1.17%-$1.98M
Alkermes plcSHS(ALKS)189,979206,778+16,799$9.95M$8.38M1.11%-$1.58M
Dyne Therapeutics, Inc.(DYN)356,657511,280+154,623$7.92M$8.24M1.09%+$315.4K
Relay Therapeutics, Inc.(RLAY)570,311447,235-123,076$10.67M$8.07M1.07%-$2.60M
Agios Pharmaceuticals, Inc.(AGIO)205,579215,529+9,950$7.63M$7.17M0.95%-$462.7K
Celcuity Inc.(CELC)64,11087,421+23,311$6.71M$6.95M0.92%+$244.5K
Neurocrine Biosciences, Inc.(NBIX)047,014+47,014$0$6.67M0.88%+$6.67M
Krystal Biotech, Inc.(KRYS)19,66819,6680$7.31M$6.54M0.86%-$769.2K
Axsome Therapeutics, Inc.(AXSM)035,000+35,000$0$6.45M0.85%+$6.45M
Warner Bros Discovery IncCOM SER A250,000200,000-50,000$6.67M$6.19M0.82%-$475.0K
Nektar Therapeutics(NKTR)86,996101,645+14,649$6.07M$6.15M0.81%+$80.9K
Uber Technologies, Inc.(UBER)071,428+71,428$0$4.89M0.65%+$4.89M
Snowflake Inc.(SNOW)10,00010,0000$2.54M$3.40M0.45%+$850.6K
An2 Therapeutics Inc0603,424+603,424$0$3.21M0.42%+$3.21M
Annexon Inc1,242,455655,948-586,507$7.09M$2.77M0.37%-$4.32M
Monte Rosa Therapeutics Inc56,05256,0520$1.36M$668.7K0.09%-$687.8K
Tectonic Therapeutic Inc46,51626,798-19,718$1.60M$624.1K0.08%-$974.9K
Sol-gel Technologies LtdSHS NEW
SHS NEW
08,307+8,307$0$617.0K0.08%+$617.0K
Acadia Pharmaceuticals Inc167,8750-167,875$4.25M$0—-$4.25M
Aclaris Therapeutics, Inc.(ACRS)400,0000-400,000$2.12M$0—-$2.12M
Amylyx Pharmaceuticals, Inc.(AMLX)297,9260-297,926$5.35M$0—-$5.35M
Cue Biopharma, Inc.(CUE)93,8190-93,819$2.96M$0—-$2.96M
Page 1 of 1
TFG Asset Management GP Ltd — 13F Holdings — Q3 2026 | TickerTrail